CLDN4 and bladder transitional cell carcinoma: EMP1, a gene implicated in cisplatin resistance and cancer recurrence39–41, and CLDN4, a tight junction gene implicated in facilitating aggressive biology in bladder cancer42, were also positively associated with TM4SF1 in TCGA-BLCA (Supplementary Fig. 11D).